Trudnyy patsient: obostreniya khronicheskoy obstruktivnoy bolezni legkikh tyazhelogo techeniya
- Autores: Nonikov V.E1, Mozzhukhina E.V1
-
Afiliações:
- Edição: Nº 15 (2012)
- Páginas: 81-83
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279906
- ID: 279906
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article considers the main recommendations for the treatment of chronic obstructive pulmonary disease (COPD), especially severe forms. In particular, the features of broncholytic and antibacterial therapy for severe exacerbation of COPD are discussed. Successful treatment of COPD exacerbations reduces the risk of a fatal outcome. In the case of use of systematic drug therapy, prevention of exacerbation and rehabilitation activities, prognosis of future course of the disease could be better.
Texto integral
Bibliografia
- Global Initiative for Chronic Obstructive Lung Diseases (NHLB/WHO Workshop Report), National Institutes of Health. 2009:90.
- Ноников В.Е. Хроническая обструктивная болезнь легких. В кн.: Основы клинической гериатрии. Практическое руководство / Под ред. С.П. Миронова и АТ. Арутюнова. М., 2008. 512 с.
- Dahl R, Greefhorst L, Novak D, et al. Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001;164(5):778-84.
- Casaburi R, Mahler D, Jones P, et al. A long term evaluation of once-daily inhaled tiotropium in Chronic obstructive pulmonary disease. Eur Respir J 2002;19(2):212-24.
- Mills NL, Miller JJ, Anand A, et al. Increased arterial stiffness in patients with COPD: a mechanism for increased cardiovascular risk Thorax 2008;63(4):206-11.
Arquivos suplementares
